Trial intelligence / Profile preview

LiBRA – Lithium treatment to prevent cognitive impairment after brain radiotherapy

2023-504071-24-00Phase 2Authorised

Sponsor
Karolinska University Hospital
Start
May 2023
Modality
Small Molecules
Countries
2
01

Overview

Phase 2, randomised, double-blind trial in brain neoplasm comparing Lithionit (lithium) arm with Placebo arm (2 arms). Planned start May 2023; status: authorised.

02

Drugs

lithium sulfate
03

Conditions

brain neoplasm

Beyond the preview

Go deeper on 2023-504071-24-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2023-504071-24-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call